These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33998063)

  • 1. Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease.
    De Paepe AE; Ara A; Garcia-Gorro C; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E
    Mov Disord; 2021 Sep; 36(9):2162-2172. PubMed ID: 33998063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and metabolic brain correlates of apathy in Huntington's disease.
    Martínez-Horta S; Perez-Perez J; Sampedro F; Pagonabarraga J; Horta-Barba A; Carceller-Sindreu M; Gomez-Anson B; Lozano-Martinez GA; Lopez-Mora DA; Camacho V; Fernández-León A; Carrió I; Kulisevsky J
    Mov Disord; 2018 Jul; 33(7):1151-1159. PubMed ID: 29676484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.
    Martinez-Horta S; Sampedro F; Pagonabarraga J; Fernandez-Bobadilla R; Marin-Lahoz J; Riba J; Kulisevsky J
    Brain Imaging Behav; 2017 Oct; 11(5):1334-1342. PubMed ID: 27730477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.
    De Paepe AE; Sierpowska J; Garcia-Gorro C; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E
    Neuroimage Clin; 2019; 24():101965. PubMed ID: 31401404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L; Gregory S; Scahill RI; Abdulkadir A; Kaller CP; Peter J; Long JD; Stout JC; Reilmann R; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Neuroimage Clin; 2018; 17():312-324. PubMed ID: 29527479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study.
    Baake V; Coppen EM; van Duijn E; Dumas EM; van den Bogaard SJA; Scahill RI; Johnson H; Leavitt B; Durr A; Tabrizi SJ; Craufurd D; Roos RAC;
    Neuroimage Clin; 2018; 19():66-70. PubMed ID: 30035003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter atrophy in presymptomatic Huntington's patients.
    Király A; Kincses ZT; Szabó N; Tóth E; Csete G; Faragó P; Vécsei L
    Ideggyogy Sz; 2016 Jul; 69(7-8):261-267. PubMed ID: 29465891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
    Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
    Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural brain correlates of irritability and aggression in early manifest Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Brain Imaging Behav; 2021 Feb; 15(1):107-113. PubMed ID: 31898092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale.
    De Paepe AE; Garcia-Gorro C; Martinez-Horta S; Perez JP; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Santacruz P; Muñoz E; Mareca C; Ruiz-Idiago J; de Diego-Balaguer R; Camara E
    Parkinsonism Relat Disord; 2022 Dec; 105():83-89. PubMed ID: 36395542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis.
    Suzuki F; Sato N; Ota M; Sugiyama A; Shigemoto Y; Morimoto E; Kimura Y; Wakasugi N; Takahashi Y; Futamura A; Kawamura M; Ono K; Nakamura M; Sano A; Watanabe M; Matsuda H; Abe O
    J Neurol Sci; 2020 Jan; 408():116545. PubMed ID: 31704285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed atrophy in posterior cingulate cortex and apathy after stroke.
    Matsuoka K; Yasuno F; Taguchi A; Yamamoto A; Kajimoto K; Kazui H; Kudo T; Sekiyama A; Kitamura S; Kiuchi K; Kosaka J; Kishimoto T; Iida H; Nagatsuka K
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):566-72. PubMed ID: 25092799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data.
    Domínguez D JF; Poudel G; Stout JC; Gray M; Chua P; Borowsky B; Egan GF; Georgiou-Karistianis N
    Cortex; 2017 Jul; 92():139-149. PubMed ID: 28482181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar Degeneration Signature in Huntington's Disease.
    Padron-Rivera G; Diaz R; Vaca-Palomares I; Ochoa A; Hernandez-Castillo CR; Fernandez-Ruiz J
    Cerebellum; 2021 Dec; 20(6):942-945. PubMed ID: 33723707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.